News

Xyrem is an oral solution that contains the active substance sodium oxybate (500mg/ml). Xyrem is indicated for the treatment of narcolepsy with cataplexy in adults. UCB said that

Under the agreement, ZBx can exercise its option during a period which starts 90 days from, and expires 120 days after, the effective date of the Option. If

The new coupling methods will greatly expand the technology’s applicability in the key drug discovery and life science research markets. The three new coupling methods, for use with

Under the agreement, Anacor and MMV will work together on the development of AN3661 through human proof-of-concept studies. AN3661 was developed as part of a research agreement signed

Pursuant to the settlement agreement, the parties have agreed to terminate the collaboration agreement. In addition, in consideration of Elite’s agreement to terminate the collaboration agreement and to

Mylan received a report from a pharmacist who had received several bottles of Mylan-Minocycline Capsules, 50 mg, including one bottle that was mislabeled as another product (Mylan-Amlodipine Tablets,

China Botanic is a company engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines (TCM), in the People’s Republic of

As per the terms of the agreement, TaiMed is responsible to pay a sum of $250,000 as an upfront payment and might pay up to $7.6m to Ambrilia

Cortex is a neuroscience company engaged in novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. The company has posted loss from operations of $986,000,